P oor health in the tropics often brings to mind infectious and parasitic diseases that thrive and spread in hot and humid climates (http://www.who.int/topics/tropical_diseases/en/ and http://www. astmh.org/education-resources/tropical-medicine-q-a/major-tropicaldiseases), rather than NCDs like cancers and heart disease, which are considered ailments of wealthy urbanized Western nations 1, 2 . NCDs refer to conditions other than injuries, maternal and perinatal conditions and nutritional deficiencies that do not involve an acute infection or parasite, and hence are not transmittable from person to person.
In the 1970s, Omran proposed 3 a theory of epidemiological transition in which, as countries develop economically and 'modernise' , there is a shift from communicable (infectious) diseases to NCDs. This linear perspective on health development has led the bulk of domestic and international health financing and policy in low-and middle-income countries to focus on infectious diseases and maternal and child health 4 . As worldwide data on deaths and disease have become more available, it has become increasingly apparent that NCDs also affect the populations of low-and middle-income nations [5] [6] [7] . The growing evidence for the relevance of NCDs as a global health issue led to a United Nations high-level meeting on the prevention and control of NCDs, following which the World Health Organization (WHO) member states committed to reducing premature mortality from four NCDs (cancers, cardiovascular and chronic respiratory diseases, and diabetes in people in the age range 30-69 years) by a quarter relative to their 2010 levels by 2025. NCDs have also been included in the United Nations Sustainable Development Goals (SDGs), with a target of reducing by one-third, relative to their 2015 levels, premature mortality from NCDs and promoting mental health and well-being by 2030; the indicator used to measure progress towards this target is the same as that of the WHO target.
Despite increasing awareness of the importance of NCDs as a global health issue, there is limited evaluation of how similarities and differences in NCD composition between low-and middle-income tropical and high-income countries should influence policies and programmes that aim to reduce their health burden 5, 8, 9 . In this Review, we use international data to compare NCDs between low-and middle-income tropical and high-income Western regions (Box 1), and use these comparisons to identify policies and interventions that could reduce their burden. We begin by describing the overall mortality burden and composition of NCDs in tropical regions in comparison to high-income countries. We then evaluate some of the potential causes of regional differences of NCDs, including genetics, infections, nutrition, healthcare and poverty. Finally, we identify a comprehensive set of actions across health, social, economic and environmental sectors aimed at reducing NCDs in low-and middle-income countries.
NCD deaths in the tropics
In 2016, life expectancy at birth in low-and middle-income tropical countries ranged from less than 53 years in Sierra Leone and Central African Republic to above 79 years in some countries in Latin America and the Caribbean, for example Costa Rica and Cuba ( Supplementary  Fig. 1 ). With the exception of the USA, in which life expectancy at birth of 78.6 years was similar to that of some better-off low-and middleincome nations, life expectancy was consistently high in high-income Western countries, surpassing 83 years in Switzerland, Spain, France, Canada and Australia.
Of the 25.3 million deaths in the four tropical regions-Africa, India (south Asia), southeast Asia, and Latin America and the Caribbeanin 2016, 8.7 million (34%) were from infectious and parasitic diseases, maternal and perinatal conditions, and nutritional deficiencies, 14.0 million (55%) from NCDs and the remainder from injuries. The share of deaths from NCDs in tropical countries had the same geographical pattern as life expectancy, ranging from below 30% in some African countries to over 80% in parts of southeast Asia and Latin America and the Caribbean, Mauritius and Seychelles (Fig. 1a) . Tropical Africa was the only region in which NCDs accounted for fewer deaths than infectious and parasitic diseases, maternal and perinatal conditions, and nutritional deficiencies (33% versus 57%). NCDs accounted for nearly 90% of all deaths in high-income Western countries, higher than their share in all tropical regions, as predicted by the epidemiological transition theory. Crude death rates from NCDs as a whole, and from age patterns of deaths from NCDs versus infections and different age structures is the main reason for higher crude NCD death rates in highincome countries. In other words, low-and middle-income tropical countries have lower NCD death rates than high-income nations at least partly because their population is younger.
One way to compare the epidemiological (versus demographic) features of NCDs across countries is to fix the age structure to a reference (standard) population, a process known as age-standardization (this is done by taking a weighted average of age-specific death rates, with the weight for each age group being its share of standard population) 10 . Once this is done, NCDs as a whole, and most individual NCDs, have higher death rates in tropical countries than they do in high-income Western countries (Figs. 1b and 2) . The exceptions to this pattern are cancers, mental, neurological and substance-abuse disorders, and endocrine, blood and immune disorders, for which age-standardized death rates are slightly lower or about the same in the tropical regions (Fig. 2) . In other words, low-and middle-income tropical countries have a disadvantage in NCDs compared to their high-income Western counterparts, as they do for infectious diseases. The largest absolute disadvantage of tropical regions is that of cardiovascular diseases, followed by chronic respiratory diseases, diabetes, kidney and other genitourinary diseases, and liver cirrhosis and other digestive diseases. In the following sections, we examine the regional patterns of cardiovascular diseases and cancers, which are the largest two groups of NCDs.
That NCDs have a substantial mortality burden in low-and middle-income countries is consistent with the historical experience of high-income countries [11] [12] [13] . For example, in 1900, the ten leading causes of death in the USA included infectious diseases such as respiratory infections, influenza, tuberculosis and diarrhoea as well as heart and kidney diseases, stroke and cancers; by 1930, these latter diseases made up four of the five leading causes of death 11, 13 . As life expectancy increased in high-income countries, age-standardized death rates declined for some NCDs (stroke and possibly kidney disease) but increased for others (cancers) 11, 12 .
Regional inequalities in cardiovascular diseases
Cardiovascular diseases accounted for 5.8 million deaths (23% of all deaths) in the four low-and middle-income tropical regions, with their share ranging from 13% in Africa to 32% in southeast Asia, compared to 2.2 million deaths (30% of all deaths) in high-income Western countries. Age-standardized death rates from cardiovascular diseases as a whole, as well as from most individual cardiovascular diseases, were higher in low-and middle-income tropical regions than in the highincome Western region (Fig. 3) .
In relative terms, the largest regional mortality disparity was that of rheumatic heart disease, with death rates in the African and Asian tropical regions many times those in the high-income Western region. Rheumatic heart disease, which is caused by rheumatic fever from group A streptococcal disease, is a classic NCD of poor communities 9, 14 . In 2016, it accounted for nearly 300,000 worldwide deaths, nearly half of which occurred in tropical Africa, India and southeast Asia. However, even in these regions, rheumatic heart disease accounted for no more than 4% of cardiovascular disease deaths in 2016.
Rheumatic heart disease was present at the beginning of the twentieth century in high-income countries, declining sharply and virtually disappearing by the 1970s, except in disadvantaged indigenous communities [14] [15] [16] . Much of this decline occurred before the introduction of antibiotics, owing to improvements in housing, hygiene, nutrition and primary healthcare 11, 14, 15 . More recent declines in middle-income tropical countries such as Costa Rica and Cuba have benefited from a combination of environmental interventions and antibiotic therapy 14 . Incidence remains high in sub-Saharan Africa and south Asia, where systematic prevention and treatment programmes are rare 9, 17 . Other cardiovascular diseases associated with infections that are more common in lowincome than in high-income countries include endomyocardial fibrosis, pericarditis and cardiomyopathy 9, 18, 19 . Like rheumatic heart disease, they accounted for a small share of cardiovascular disease deaths in 2016.
Box 1

Low-and middle-income tropical countries
Physicians and medical researchers have had a longstanding interest in health in the tropics because its climate and ecology can influence human health directly or by changing the viability and dynamics of disease vectors. In the tropics and elsewhere, health is also strongly influenced by the economic resources available to countries and individuals. In this Review we evaluate the status of NCDs by focusing on low-and middle-income tropical countries as a way to bridge two parallel bodies of work in global health: tropical diseases and NCDs.
Countries were classified as 'tropical' if half or more of their land area was between the Tropic of Cancer and Tropic of Capricorn. This classification excludes some low-income countries, such as Bangladesh and Pakistan. Similarly, the focus on low-and middleincome excludes some tropical countries, such as Singapore. For reporting, we organised low-and middle-income tropical countries into the following regions.
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Although the near-disappearance of rheumatic heart disease from high-income nations has, appropriately, put a spotlight on its persistent burden in the poorest countries, the largest absolute mortality inequality between tropical and high-income regions is unequivocally that of stroke and ischaemic heart disease ( Fig. 3 ) because they have a large mortality burden-more than three-quarters of cardiovascular disease deaths in every region. Historical data from high-income countries consistently show a decline in stroke death rates from as early as 1900, driven initially by a sharp decline in haemorrhagic stroke and subsequently by both haemorrhagic and ischaemic subtypes 16 . Limited data from middle-income countries also show similar trends 16 . High blood pressure is the single most important risk factor for stroke, especially for haemorrhagic stroke 20 , and is addressed later in this Review. Some stroke risk factors, such as sickle cell, are nonetheless predominantly tropical 21 . How ischaemic heart disease changes during economic and health development is more complex than trends for rheumatic heart disease and stroke, which both tend to decline as overall health improves 11, 12, 16, 22 . In high-income countries, ischaemic heart disease mortality increased in the first half of the twentieth century and declined subsequently, with similar trends seen today in middleincome countries with longitudinal data including Seychelles, South Africa and parts of Latin America 11, 16, 22 Some studies have found a low prevalence of markers of coronary atherosclerosis, a precursor of ischaemic heart disease, in remote indigenous populations of the tropicssuch as the Masai and Samburu in east Africa in the 1960s 23, 24 , the Kalahari Bushmen in the 1970s 25 and the Tsimane in South America in the 2010s 26 -even though diets, including the share of carbohydrates versus animal-source foods, vary substantially among these groups. It is, however, unclear how representative these groups are of the populations of the larger tropical regions where they live, and studies in the same and other tropical regions have found high levels of coronary disease or its precursors 24, 27 . The variations in ischaemic heart disease rates and trends even within low-and middle-income countries may be because the disease has diverse causes, including chronic inflammation, fetal and early life malnutrition and stunted growth, smoking, heavy episodic (binge) alcohol drinking, and low consumption of fruits and vegetables, which are present to varying degrees in low-and middle-income countries. The large burden of ischaemic heart disease and stroke in low-and middle-income countries, and the similarities and differences in their causes compared to high-income countries, necessitate going beyond the simple paradigm of epidemiological transition to identify interventions that effectively address their local causes and health systems that are able to help patients with these conditions.
Diverse regional patterns of cancer mortality
Cancers accounted for 2.4 million deaths in 2016 (9% of all deaths) in the four low-and middle-income tropical regions, with their share ranging from 6% in Africa to 18% in Latin America and the Caribbean, compared to 1.9 million deaths (26% of all deaths) in high-income Western countries. Cancers are a heterogeneous group of diseases, so the regional variations may differ by type of cancer 8, 28 . After age-standardization, death rates from many cancers were lower in the tropical regions than in high-income Western countries, with the difference largest for lung cancer, followed by colorectal and pancreatic cancers (Fig. 4) . However, cervical, head and neck, liver, stomach and oesophagus cancers had higher death rates in all or some tropical regions than in the highincome Western region. Prostate cancer death rates were higher in tropical Africa and Latin America and the Caribbean than in high-income countries, but the opposite was true in India and southeast Asia.
The regional differences in cancer death rates are due to a combination of differences in incidence and survival. Variations in cancer incidence are, in turn, due to different exposures to its major risk factors including smoking and alcohol use, chemicals and radiation in the environment, infections, diet, reproductive and sexual practices, and metabolic and hormonal factors [28] [29] [30] [31] . Access to and utilization of screening and treatment also matters when precancerous lesions or early-stage cancer can be effectively treated, such as for cervical cancers. The incidence of most cancers in low-and middle-income tropical regions was similar to, or lower than, that in high-income countries, with the difference largest for prostate and breast cancers, followed by lung and colorectal cancers ( Supplementary Fig. 3 ). That prostate and breast cancers had lower incidence but higher death rates in low-and middleincome regions is because of worse cancer survival 32 . Cervical, liver and stomach cancers were the only cancers with higher age-standardized incidence in all or most low-and middle-income regions. Kaposi's sarcoma, of which HIV/AIDS is the leading cause, was unfamiliar to many physicians in the early 1980s, and has emerged as a leading cancer in Africa as a result of the HIV/AIDS epidemic, and the single most common cancer in countries such as Zimbabwe and Mozambique.
Almost all cervical cancers are caused by infection with human papillomavirus, which is mostly transmitted via sexual contact, and NCDs include: cancers; cardiovascular diseases; diabetes; endocrine, blood and immune disorders; non-infectious respiratory, digestive (including liver), and genitourinary diseases; neurological conditions; mental and substance-use disorders; congenital anomalies; and sense-organ, skin, musculoskeletal and oral/dental conditions. The mortality and population data were taken from the WHO global health estimates 85 . All results are for females and males combined. Death rates were age-standardized to the WHO standard population 10 .
Review ReSeARCH around 90% of non-cardia stomach cancers (that is, stomach cancer not including the upper stomach) are due to Helicobacter pylori infection (an estimated 70% of all stomach cancers are non-cardia) 33, 34 , a bacterium transmitted via contaminated food and water. Given their main routes of transmission, both infections are strongly related to the hygiene environment and behaviour. Cervical and stomach cancer incidence and deaths have declined steadily in high-income countries and in emerging economies, owing to improvements in water and sanitation, housing, electrification and refrigeration, and access to soap and other basic hygiene necessities, as well as effective screening and treatment programmes for cervical cancer [35] [36] [37] [38] [39] . Poorer countries fare worse in terms of the social, environmental and health-system determinants of these two infection-related cancers. Further, although an effective vaccine for human papillomavirus now exists, most lower-income nations have not introduced human papillomavirus vaccination, partly owing to its cost 28, 40 . As a result, in 2016, nearly two thirds (63%) of worldwide deaths from cervical cancer deaths occurred in the four tropical regions covered in this Review, compared with 7% in high-income Western countries.
Liver cancer, which is also more common in low-and middle-income tropical countries than in high-income countries, has multiple causes, including hepatitis B and C viral infection, mycotoxins, especially aflatoxin from contamination of foods such as maize and groundnuts during storage, liver flukes, which are transmitted by eating infected raw freshwater fish, smoking, alcohol use, adiposity and diabetes 28, [41] [42] [43] . In high-income countries, hepatitis B virus infection has declined, while adiposity and diabetes have increased [43] [44] [45] , and alcohol use and smoking have declined in some countries and increased in others 46 . Owing to these complex trends, liver cancer declined in the middle decades of the twentieth century in high-income countries, followed by a continued decline in some countries and an increase in others, such as the USA and the UK 36 . Currently, the highest worldwide hepatitis B infection rates are those in tropical Africa, where hepatitis B virus vaccine coverage, especially for the birth dose, is lowest 42 . As a result, despite the availability of an effective vaccine, hepatitis B infection, in combination with aflatoxin, remains a key determinant of the large burden of liver cancer in Africa 28 , especially in west Africa. Although infections remain an important cause of cancers in lowand middle-income tropical countries, other cancer risk factors are increasingly important. In particular, smoking accounts for about 20% of all cancer deaths in low-and middle-income countries, compared to 30% in high-income countries 29 . However, smoking is rapidly shifting from high-income to low-and middle-income countries owing to differences in taxes and other tobacco control measures, and fuelled by the tobacco industry's tactics 47 . Harmful alcohol use, which accounts for about 5% of all cancer deaths worldwide is also common in Latin America, and rising in Africa and Asia 48 . The coexistence of cancers that are largely or partly caused by infections and those that are related to smoking and alcohol use means that reducing cancer burden in lowand middle-income countries must include social and environmental improvements such as clean water and sanitation, electrification and refrigeration to reduce the risk of infections, vaccination to protect against infections, and effective tobacco and alcohol control. However, the benefits of some of these actions will take decades to materialize. Therefore, health systems should be equipped to detect and treat precancerous signs or early-stage cancers 49 .
Causes of NCDs in low-and middle-income countries
The data presented in this Review demonstrate that not only are NCDs present in low-and middle-income tropical countries, but that also, after accounting for differences in age structure, the populations of A point above the dotted line has a higher death rate in the tropical region than in the high-income Western region, and a point below the dotted line has a lower death rate. Data are for females and males combined. Congenital heart anomalies are not classified as a cardiovascular disease by the international classification of disease system. They are shown here alongside the international classification of disease cardiovascular disease categories to show regional variations in their death rates 9 . Mortality and population data are taken from the WHO global health estimates 85 . Death rates were age-standardized to the WHO standard population 10 .
these countries experience a higher burden of NCDs than high-income Western countries. Beyond a general disadvantage, there are differences in the composition of NCDs across low-and middle-income tropical regions compared to the high-income Western region. Here we examine some of the potential determinants of these regional differences.
Genetics
Genetic variants that increase the risk of NCDs may have different regional frequencies. For example, the sickle haemoglobin gene (HbS), which is protective against malaria, is more frequent in tropical regions, especially in Africa, than in other parts of the world, with three-quarters of children with a haemoglobinopathy born in sub-Saharan Africa 50 . Within Africa, the frequency of the HbS gene is associated with the historical geographical distribution of malaria, supporting the hypothesis that a classical tropical disease has shaped the geographical distribution of an NCD via genetic selection 51, 52 . It is possible that genetic susceptibility loci for other NCDs are also over-or under-represented in tropical regions. For example a variant on chromosome 17q21, which is more common in men of African descent than in non-African men, is associated with an increased risk of prostate cancer 53, 54 . How much this single-nucleotide polymorphism accounts for the higher rates of prostate cancer in tropical Africa, however, is unclear because its causal effect is not fully established and its frequency varies across Africa. More broadly, currently known genetic variants do not account for the large regional variations in NCD rates seen earlier or for the fact that disease rates change over periods of years and decades. Nor do genetic variants explain why migrants from the tropics to Western countries tend to converge to disease rates in the host environment within a few generations. Therefore, it is important to evaluate genetics alongside social and environmental determinants in studying worldwide disease patterns.
Obesity and other cardiometabolic risks
One of the factors underlying the claims that NCDs, especially ischaemic heart disease and stroke, are uncommon in lower-income tropical countries is the assumption that diet worsens as societies become more affluent and urbanized, leading to higher rates of obesity and diabetes, and higher blood pressure and lipids 1, 7, [55] [56] [57] [58] . However, affluence and urban living can lead to improvements as well as worsening in diet. For example, consumption of fruits, which are beneficial for NCDs, is seasonal in poorer countries, while more affluent populations use food trade, transportation and storage to consume fruits year-round and hence have higher average consumption 16, 46, 59 . Body-mass index (BMI) and associated metabolic conditions also have varied patterns in relation to national income 60 . BMI is currently lower in tropical Africa and south and southeast Asia than in the high-income Western region, but is about the same in the latter region and Latin America and the Caribbean (Fig. 5) 
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. In contrast to BMI, diabetes prevalence is about the same, or higher, in most low-and middle-income regions than in the high-income Western region 44 . The regional discordance between diabetes and elevated BMI, which is an important cause of diabetes, might be partly due to phenotypic variations arising from inadequate fetal and childhood nutrition and growth in low-and middle-income countries as discussed below, leading to earlier onset of β-cell dysfunction. Additionally, the better-resourced health systems in high-income countries can identify people at high risk of diabetes at an earlier stage, and use lifestyle and dietary modification and drugs to delay or prevent its onset.
In an even more extreme form of disadvantage in low-and middleincome regions, the highest worldwide blood pressure levels are those in sub-Saharan Africa, with blood pressure also high in south Asia, whereas high-income nations have some of the lowest blood pressure levels in the world 61 . Although historically, high as well as low blood pressure levels were observed in tropical countries 27 , blood pressure levels seem to have increased in Africa and Asia over the past few decades, while declining sharply in high-income countries 61, 62 . Of the cardiometabolic risk factors, only cholesterol reflects the classical epidemiological transition model, and is currently lower in tropical Africa, south Asia, and east and southeast Asia than in high-income Western countries (Fig. 5) 
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.
Fetal and early-life environment and nutrition
Nutrition and environment during the fetal, childhood and adolescence periods are an important determinant of NCDs. In the second half of the twentieth century, researchers realised that children born or growing during periods of famine, war and economic hardship had A point above the dotted line has a higher death rate in the tropical region than in the high-income Western region, and a point below the dotted line has a lower death rate. Mortality and population data were taken from the WHO global health estimates 85 Death rates were age-standardized to the WHO standard population 10 . Kaposi's sarcoma is not shown as a separate category because its deaths were reported together with those from HIV/ AIDS in the WHO global health estimates. See Supplementary Fig. 3 for incidence.
Review ReSeARCH a higher risk of some NCDs in adulthood [64] [65] [66] . The thrifty phenotype hypothesis 67 , which summarises these findings, postulates that earlylife undernutrition increases the risk of NCDs, especially if followed by rapid or excessive weight gain 68 . In parallel, nutritionists and social scientists noted that, although there is a strong genetic influence on individual height, changes in height of an entire population are driven by social, environmental and nutritional status during childhood and adolescence [69] [70] [71] . Being taller is associated with enhanced longevity, lower risk of cardiovascular and respiratory diseases, and higher risk of some cancers 65, 72 . These studies collectively demonstrate that fetal, childhood and adolescent environment and nutrition influence NCDs, with at least part of the effects mediated by linear growth.
In the early twentieth century, the shortest heights in the world were those in tropical Asia and Andean Latin America 72 . Asians and Latin Americans grew taller over the course of the twentieth century, with some of the largest worldwide gains in height occurring in east Asia. In India and other south Asian nations, height in adulthood has plateaued at lower levels than those experienced elsewhere 72 . Adults in subSaharan Africa were taller than those in Asia and parts of Latin America in the early twentieth century, but fell behind because Africans born in the last three decades of the twentieth century are shorter than their predecessors 72, 73 . Poor early-life nutrition and stunted growth may be partly responsible for the fact that some NCDs are high in low-income countries, and decline as economies develop, the opposite of what is predicted by a simple epidemiological transition model.
Infections, parasites and mycotoxins
A distinct feature of the NCDs in tropical countries, especially in the lowerincome regions of tropical Africa and south Asia, is the importance of diseases with infectious, parasitic and fungal origins (Box 2). As discussed earlier, infection-related NCDs include rheumatic heart disease, liver cirrhosis, cervical, liver and stomach cancers, and Kaposi's sarcoma. Infections and parasitic diseases also contribute to other NCDs. For example, infectious respiratory diseases increase the risk of chronic obstructive pulmonary disease 74 , schistosomiasis and other helminth infections increase the risk of genitourinary diseases 75 , and inflammation 85 and on risk factors from the NCD Risk Factor Collaboration (http://www.ncdrisc.org) 44, 45, 61, 63 . Death rates and risk factors were age-standardized to the WHO standard population 10 .
Box 2
Bidirectional links between infections and NCDs
Not only are infectious diseases an important cause of ill health in low-and middle-income countries, they also affect some NCDs, including many cancers 19, 31, 86 . That infections cause cancers was hypothesized centuries ago, and emerged as a subject of systematic research at the end of the nineteenth century, after Pasteur and Koch established the their role as a cause of disease in general 31, 86 . Difficulties in establishing a clear link between specific infectious agents and cancer, together with the identification of ionizing radiation, soot, tar and other chemicals as causes of cancer, led to a lack of interest in, and even dismissal of, experimental results on infection and cancers in animals. After electron microscopy facilitated the discovery of the endogenous retroviruses, which could enter the host cell and modify its genome, interest in infectious, especially viral, causes of cancers revived. Researchers took advantage of new laboratory techniques and epidemiological studies in populations with high cancer rates to identify the causal roles of human T-cell leukaemia retrovirus (HTLV-1) in leukaemia, hepatitis B and C viruses in liver cancer, human papillomavirus in cervical cancer, Epstein-Barr virus in Burkitt's lymphoma, and HIV in Kaposi's sarcoma and nonHodgkin's and Hodgkin's lymphoma 31 . Further research as well as chance observations (for example, high rates of acute liver disease in poultry fed with groundnuts) led to discovering non-viral communicable causes of cancers including bacteria, parasitic flukes and fungi 31 . The mechanisms for the carcinogenic effects of infections are varied and include oncogene activation, chronic inflammation, metaplasia of epithelium, release of carcinogens, general immunosuppression and loss of tumour suppressor ability 19 .
The relationship between infections and NCDs is bidirectional. For example, tobacco smoking, alcohol use and diabetes not only affect NCDs, but also increase the risk of infectious diseases [87] [88] [89] [90] [91] . The established or hypothesized mechanisms for these effects include reduced immune function, such as through adverse impacts on macrophage and leukocyte function and lower production of interleukins; increased viral production and virulence in hyperglycaemic environments or after alcohol use; and lower adherence to anti-retroviral treatment and riskier sexual behaviour for alcohol and HIV 90, 92 . Therefore, the rising prevalence of smoking, alcohol use and diabetes in low-and middle-income countries will set back efforts to combat classical tropical diseases such as tuberculosis and other respiratory infections [93] [94] [95] . The bidirectional relationship also provides an opportunity for integration of disease prevention, detection and treatment [96] [97] [98] . For example, screening tuberculosis patients can help to increase the currently low rate of diabetes diagnosis 98 , and smoking and alcohol cessation and glycaemic control may improve the prognosis of tuberculosis patients. Direct evidence on the benefits of integration is currently lacking, especially from low-and middle-income countries with the highest infection burden, and will inevitably depend on extending health system access and utilization, health workforce training, availability of medicines for treatment, and patient follow-up to ensure treatment adherence.
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as a result of chronic and repeated infections increases the risk of cardiovascular diseases 19, 76 . Although infections remain an important cause of NCDs in poor countries and communities, the burden of most infection-related NCDs is comparable to or smaller than that of other NCDs. For example, colorectal cancer, which is caused by high consumption of red and processed meat and low intake of dietary fibre now has a comparable burden to liver and stomach cancers in low-and middle-income tropical regions (Fig. 4) . Age-standardized death rates from breast cancer are higher than those of cervical cancer in every tropical region except Africa, where their mortality burden is about the same. Similarly, prostate cancer has emerged as an important cause of death among men across low-and middle-income tropical regions, with a higher age-standardized death rate than liver or stomach cancer in some regions. Finally, NCDs with non-infectious origins are not only an important cause of mortality in low-and middle-income countries, but they may increase the risk of infectious diseases (Box 2). This reciprocal relationship should motivate a more integrated response to communicable and non-communicable diseases.
Poverty
More than two-thirds of people in the poorest countries in tropical Africa and about 12% in India live on less than I$1.90 per day (I$, international dollar that is adjusted for purchasing power and inflation; https://data.worldbank.org/indicator/SI.POV.DDAY?). The poor experience higher rates of NCDs partly because many causes of NCDs, including poor nutrition at all stages of life; inadequate housing, water, sanitation and electricity; smoking and elevated blood pressure, tend to be associated with poverty 5, 9, 60, [77] [78] [79] . People in poor countries and communities, and those with lower income, also have more limited access to high-quality healthcare, because health infrastructure, personnel Box 3 effective interventions for NCDs in low-and middle-income tropical countries
• Increase access to and encourage cervical cancer screening for all women through opportunistic screening with visual inspection and outreach programmes for vulnerable groups, and treat precancerous lesions.
• Treatment of streptococcal pharyngitis with effective antibiotics to prevent acute rheumatic fever and spread of group A streptococcus.
• Measure blood pressure and use off-patent medicines to treat hypertension at primary care level, especially where laboratories for risk-based management of cardiovascular diseases are limited.
• Equip primary care for early detection of diabetes, treatable cancers, and kidney disease, and referral into effective treatment pathways.
• Implement newborn and paediatric NCD services for genetic and congenital disorders, type I diabetes, asthma and paediatric cancers in primary care, effective referral pathways to specialist care, treatment and management of such conditions and their complications, and patient and parent education and empowerment programmes.
• Use mobile phones and other digital technologies to create a decentralized emergency response system, train and equip first responders for stabilization and risk stratification of patients with possible myocardial infarction and stroke, and implement community care pathways for rapid transfer of such patients to a specialized healthcare facility.
• Implement pharmacological and psychosocial interventions for mental health conditions including depression and schizophrenia at the community and primary care level 101 .
Research and development
• Develop an effective vaccine to prevent Helicobacter pylori infection.
• Develop robust and low-cost diagnostic tools and devices for detection of early-stage cancers in the community setting, as has been done for HIV and other infectious diseases.
• Characterize NCD and NCD risk factor phenotypes and traitsmulti-morbidity with multiple communicable diseases and NCDs, and co-exposure to multiple environmental, infectious and physiological NCD risk factors-to identify optimal packages of interventions.
• Investigate, in epidemiological and health service studies, the aetiological relationship between infectious diseases and NCDs, and the feasibility and benefits of integrating their diagnoses and treatment.
Reducing the burden of NCDs in low-and middle-income tropical countries requires a combination of prevention, early detection and treatment. We present here some interventions and policies to address NCDs that have a large burden in lowand middle-income countries (such as stroke, ischaemic heart disease and some cancers) as well as those predominant in such populations (such as cervical cancer, rheumatic heart disease and haemoglobinopathies). In selecting these strategies, we used studies and reports that had quantitatively or qualitatively analysed the expected impacts of health interventions, such as the Disease Control Priorities 49, 99, 100 , the Lancet Series on NCDs 5 , the Lancet Global Mental Health Series 101 , and the Lancet Series on Maternal and Child Nutrition 102, 103 , as well as clinical guidelines such as those by the WHO and the National Institute for Health and Care Excellence. In relevant cases, such as for emergency response, we adapted the recommendations so that they can be implemented in settings with limited transportation and healthcare infrastructure.
Environment, nutrition and health behaviours
• Provide access to safe and clean housing, water, sanitation, electricity and refrigeration to reduce infectious and parasitic causes of NCDs.
• Implement public health programmes and social and agricultural policies that improve maternal, neonatal and child nutrition 102, 103 .
• Implement comprehensive tobacco and alcohol control, including taxation, warning labels, public smoking bans, and restriction of sales, marketing and advertising 49, 104 .
• Eliminate industrial transfats in food supply; reduce salt in processed foods; implement food policies that increase access to and consumption of fruits and vegetables; and tax and restrict the sales and marketing of sugar-sweetened beverages and other refined carbohydrates 100 .
Healthcare
• Implement universal, financially and physically accessible, high-quality primary and specialist care systems, with workforce, infrastructure and medicines equipped to manage NCDs, and effective referral pathways from primary to specialist care 104, 105 .
• Implement and increase the coverage of school and communitybased human papillomavirus and hepatitis B virus vaccination (including birth dose for hepatitis B virus to prevent mother-tochild transmission) 49 .
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and technologies are more restricted or because they cannot afford the out-of-pocket cost of services. Limited primary care leads to low rates of diagnosis and treatment, or late diagnosis. For example, fewer women are screened and treated for cervical cancer and fewer people with hypertension and diabetes are diagnosed and treated in lower-income than in high-income countries 5, [80] [81] [82] . Late diagnosis, typically when complications arise, coupled with more limited specialist care, worsens the prognosis of NCDs in low-and middle-income countries compared to high-income nations 32, 52, 83 . Given its central role in pathogenesis of NCDs, the poverty of individuals and communities, and not inherent features of the tropics, is the most important determinant of the higher NCD rates in the lower-income tropical countries and regions, compared to high-income nations as well as to the better-off region of Latin America and the Caribbean.
Actions to reduce NCDs in low-and middle-income countries
The data presented in this Review demonstrate that NCDs are an important cause of ill health and early death in low-and middle-income tropical countries, and after accounting for differences in age, most NCDs have a higher mortality burden than in high-income Western countries. Therefore, reducing the burden of NCDs is essential for improving health in low-and middle-income tropical countries and reducing global health inequalities.
The causes of NCDs in low-and middle-income tropical countries are diverse and include poor nutrition and living environment, infections, insufficient regulation of tobacco and alcohol, and under-resourced and inaccessible healthcare. Although much of the epidemiological research has focused on the effect of these factors on individual NCDs, they often lead to multiple communicable and NCDs in the same people and communities, leading to multi-morbidity 84 . Multiple co-occurring diseases and risk factors can have amplifying effects and lead to overall poor health and loss of productivity. At the same time, the shared causes and aetiologies of these conditions, and their overlap, provides an opportunity for systematic integration of public health and healthcare interventions for their prevention and treatment. Doing so requires better data on the patterns of multimorbidity among communicable and non-communicable diseases and their risk factors in low-and middle-income countries because they may be different from those in high-income countries (Box 3).
Underpinning these proximal determinants is a background of poverty, food insecurity (in terms of both quantity and quality), and insufficiency of infrastructure and services related to housing, water, sanitation, transportation and healthcare that afflict poor countries, communities and families. These challenges are the focus of the SDGs. The SDGs have broadened the development agenda of their predecessor, the Millennium Development Goals, whose health-related goals and targets focused on maternal and child health and infectious diseases. As stated earlier, SDGs have a target related to reducing NCD mortality, although this target excludes some important NCD causes of death in low-and middle-income tropical countries such as kidney, liver and other genitourinary and digestive diseases. Alongside this NCD mortality target, SDGs have targets for reducing tobacco and alcohol use (important causes of NCDs throughout the world), and for increasing universal health coverage (essential for enhancing timely diagnosis and treatment of NCDs and their risk factors in an equitable manner). The momentum generated by the SDGs provides an opportunity to turn political attention to NCDs. To succeed in reducing the large burden of NCDs in low-and middle-income countries and global health inequalities requires (1) identifying interventions and programmes that can be scaled up in resource-limited settings to effectively lower the burden of NCDs (Box 3) and (2) a substantial increase in domestic as well as international financing that supports low-and middle-income countries in sustained actions against NCDs.
